News & Press
VPM attends the TBVI Annual Meeting
VPM will present the latest data on the novel tuberculosis vaccine – VPM1002 at the Tuberculosis Vaccine Initiative Partner Meeting from 3 – 6 April 2023 in Les Diablerets, Switzerland

VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG
We are pleased to announce the successful completion of a clinical client project for Memo Therapeutics AG (MTx), Switzerland. The project included a Phase I clinical trial with AntiBKV, an antibody targeting BK polyomavirus (BKV) infection in renal transplant patients. VPM oversaw the clinical trial and performed translational project management, whereas the Australian cooperation partner and contract research organization (CRO) Accelagen managed the trial, yielding positive results, with all endpoints met. Click here for more information.
Press release on the results of a novel tuberculosis vaccine tested in a large phase III trial against severe respiratory infectious diseases
The course of respiratory infectious disease pandemics, will strongly depend on how quickly medications or specific vaccines against the pathogens are available. Researchers wanted to investigate in a phase III trial whether the vaccine candidate VPM1002 is also protective against an infection with the novel SARS-CoV-2. The large-scale study has been carried out at several hospitals in Germany and included older people that are susceptible to severe course of the disease. Read about the results here!
Career
Zur Verstärkung unseres Teams im Bereich Finanzen suchen wir in Vollzeit zum nächstmöglichen Zeitpunkt einen: MANAGER FINANCE & CONTROLLING. Mehr dazu hier!
To support our team of Project Managers responsible for company and client projects we are looking for a PROJECT MANAGER to join our team at the earliest opportunity (full time employment). Read more!
To support our Quality Assurance Team we are looking for a QUALITY ASSURANCE MANAGER or ASSISTANT QUALITY ASSURANCE to join our team at the earliest opportunity (full time employment). Read more!